Tenet Healthcare (THC) Tops Q4 EPS by 73c; Guides

Tenet Healthcare (NYSE: THC) reported Q4 EPS of $1.96, $0.73 better than the analyst estimate of $1.23. Revenue for the quarter came in at $4.99 billion versus the consensus estimate of $4.91 billion.

GUIDANCE:

Tenet Healthcare sees Q1 2023 EPS of $1.00-$1.23. Tenet Healthcare sees Q1 2023 revenue of $4.7-4.9 billion.

Tenet Healthcare sees FY2023 EPS of $4.68-$5.85. Tenet Healthcare sees FY2023 revenue of $19.7-20.1 billion.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Dutch Bros Inc. (BROS) PT Raised to $90 at DA Davidson on Sales/Earnings Upside
• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance